MANGALAM

Mangalam Drugs And Organics Share PriceMangalam Drugs and Organics

₹105.9
2.25 (2.17%)
As on 05 June, 2023 | 11:02 BSE: 532637 NSE: MANGALAM

Mangalam Drugs And Organics Performance

Day Range

  • Low
  • High
105.9

52 Week Range

  • Low
  • High
105.9
  • Open Price
  • Previous Close
  • Volume

Start SIP in Mangalam Drugs and Organics

Start SIP

Mangalam Drugs And Organics Share Price

  • Over 1 Month -7.71%
  • Over 3 Month -3.26%
  • Over 6 Month -26.44%
  • Over 1 Year -24.79%

Mangalam Drugs And Organics Key Statistics

P/E Ratio 132
PEG Ratio -1.4
Market Cap Cr 168
Price to Book Ratio 1.1
EPS 0.8
Dividend 0
Relative Strength Index 36.56
Money Flow Index 19.49
MACD Signal -1.4
Average True Range 3.86

Mangalam Drugs And Organics Investment Rating

  • Master Rating:
  • Mangalam Drugs & Orgs. has an operating revenue of Rs. 372.25 Cr. on a trailing 12-month basis. An annual revenue de-growth of -17% needs improvement, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 13 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 104 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Mangalam Drugs and Organics Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 9063108109120
Operating Expenses Qtr Cr 915710099111
Operating Profit Qtr Cr 0681010
Depreciation Qtr Cr 33333
Interest Qtr Cr 33343
Tax Qtr Cr -1011-2
Net Profit Qtr Cr -40237

Mangalam Drugs And Organics Technicals

EMA & SMA

Current Price
₹105.9
2.25 (2.17%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • ₹107.71
  • 50 Day
  • ₹110.16
  • 100 Day
  • ₹114.73
  • 200 Day
  • ₹121.43
  • 20 Day
  • ₹108.42
  • 50 Day
  • ₹109.34
  • 100 Day
  • ₹113.01
  • 200 Day
  • ₹127.55

Mangalam Drugs And Organics Resistance and Support

PIVOT
₹104.35
Resistance
First Resistance ₹105.7
Second Resistance ₹107.75
Third Resistance ₹109.1
RSI 36.56
MFI 19.49
MACD Single Line -1.4
MACD -1.85
Support
First Resistance ₹102.3
Second Resistance ₹100.95
Third Resistance ₹98.9

Mangalam Drugs And Organics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 58,665 2,665,151 45.43
Week 61,395 2,900,895 47.25
1 Month 51,104 2,282,309 44.66
6 Month 47,502 1,805,076 38

Mangalam Drugs And Organics Result Highlights

Mangalam Drugs and Organics Synopsis

NSE-Medical-Generic Drugs

Mangalam Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 372.25 Cr. and Equity Capital is Rs. 15.83 Cr. for the Year ended 31/03/2023. Mangalam Drugs and Organics Ltd. is a Public Limited Listed company incorporated on 18/04/1972 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1972PLC116413 and registration number is 116413.
Market Cap 167
Sales 372
Shares in Float 0.79
No of funds 4
Yield 0.68
Book Value 1.08
U/D Vol ratio 0.6
LTDebt / Equity 12
Alpha -0.14
Beta 0.51

Mangalam Drugs and Organics

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 50.32%50.32%50.42%50.42%
Foreign Portfolio Investors 0.1%0.1%0.1%0.1%
Financial Institutions/ Banks 0.01%
Individual Investors 44.22%44.27%44.13%44.18%
Others 5.36%5.31%5.35%5.29%

Mangalam Drugs and Organics Management

Name Designation
Mr. Govardhan M Dhoot Chairman & Managing Director
Mr. Brijmohan M Dhoot Whole Time Director
Mr. Rakesh K Milwani Non Exe.Non Ind.Director
Mr. Rukmesh P Dhandhania Independent Director
Mrs. Nidhi S Mundada Independent Director
Mr. Praveen Saxena Independent Director

Mangalam Drugs And Organics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Mangalam Drugs And Organics Corporate Action

Date Purpose Remarks
2023-05-30 Audited Results
2023-02-13 Quarterly Results
2022-11-11 Quarterly Results
2022-08-05 Quarterly Results
2022-05-26 Audited & Quarterly Results

Mangalam Drugs and Organics FAQs

What is Share Price of Mangalam Drugs and Organics ?

Mangalam Drugs and Organics share price is ₹105 As on 05 June, 2023 | 10:48

What is the Market Cap of Mangalam Drugs and Organics ?

The Market Cap of Mangalam Drugs and Organics is ₹167.6 Cr As on 05 June, 2023 | 10:48

What is the P/E ratio of Mangalam Drugs and Organics ?

The P/E ratio of Mangalam Drugs and Organics is 132 As on 05 June, 2023 | 10:48

What is the PB ratio of Mangalam Drugs and Organics ?

The PB ratio of Mangalam Drugs and Organics is 1.1 As on 05 June, 2023 | 10:48

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number